The company's objective is to provide scientific and strategic direction in all areas at the intersection of healthcare systems, immunization, and essential medicines. The company may hold interests in other companies, acquire, operate, manage, and dispose of real estate and intellectual property rights, establish subsidiaries and branches in Switzerland and abroad, and perform all acts that arise from its purpose or are suitable to promote its development or that of the group. Furthermore, the company may participate directly or indirectly in group financing operations, including by granting loans to its direct or indirect shareholders or other group companies or providing securities in the form of guarantees, sureties, or other securities to third parties, even if these loans or securities, which may be provided free of charge or for a fee, are in the exclusive interest of its direct or indirect shareholders or other group companies.